DRG International, Inc.
Records under this name other than patents DRG International, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to DRG International, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,017,737 | Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor Term ended Term ended Jul 14, 2024 · USPTO record | Term ended | Term ended Jul 14, 2024 | USPTO record |
| US 7,411,048 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids Term ended Term ended May 27, 2024 · USPTO record | Term ended | Term ended May 27, 2024 | USPTO record |
| US 7,320,894 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor Term ended Term ended Apr 14, 2024 · USPTO record | Term ended | Term ended Apr 14, 2024 | USPTO record |
| US 7,749,713 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor Term ended Term ended Apr 13, 2024 · USPTO record | Term ended | Term ended Apr 13, 2024 | USPTO record |
| US 7,649,081 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor Term ended Ended no later than Nov 19, 2022 · USPTO record | Term ended | Ended no later than Nov 19, 2022 | USPTO record |
| US 7,998,691 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor Term ended Term ended Nov 19, 2022 · USPTO record | Term ended | Term ended Nov 19, 2022 | USPTO record |
| US 8,003,338 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor Term ended Term ended Nov 19, 2022 · USPTO record | Term ended | Term ended Nov 19, 2022 | USPTO record |
| US 8,263,352 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor Term ended Ended no later than Nov 19, 2022 · USPTO record | Term ended | Ended no later than Nov 19, 2022 | USPTO record |
| US 8,304,197 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor Term ended Ended no later than Nov 19, 2022 · USPTO record | Term ended | Ended no later than Nov 19, 2022 | USPTO record |
| US 8,304,258 | Methods of producing monoclonal antibodies specific for human hepcidin Term ended Term ended Nov 19, 2022 · USPTO record | Term ended | Term ended Nov 19, 2022 | USPTO record |